Phase I dose-escalation study of plitidepsin in combination with sorafenib or gemcitabine in patients with refractory solid tumors or lymphomas-Reference-Cited by-同舟云学术

Phase I dose-escalation study of plitidepsin in combination with sorafenib or gemcitabine in patients with refractory solid tumors or lymphomas

Published:2017-03 Issue:3 Volume:28 Page:341-349
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Aspeslagh Sandrine,Stein Mark,Bahleda Rastilav,Hollebecque Antoine,Salles Gilles,Gyan Emmanuel,Fudio Salvador,Extremera Sonia,Alfaro Vicente,Soto-Matos Arturo,Soria Jean-Charles

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference24 articles.

1. Phase II study of biweekly plitidepsin as second-line therapy in patients with advanced malignant melanoma;Eisen;Melanoma Res,2009

2. Phase II study of weekly plitidepsin as second-line therapy for small cell lung cancer;Eisen;Lung Cancer,2009

3. Phase II study of plitidepsin 3-h infusion every 2 weeks in patients with unresectable advanced medullary thyroid carcinoma;Baudin;Am J Clin Oncol,2010

4. Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin’s lymphoma;Ribrag;Haematologica,2013

5. Abstract 5430: eEF1A2 is a new target for anticancer therapy;Losada;Can Res,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plitidepsin: Mechanisms and Clinical Profile of a Promising Antiviral Agent against COVID-19;Journal of Personalized Medicine;2021-07-16

2. Enriching cancer pharmacology with drugs of marine origin;British Journal of Pharmacology;2019-12-23

3. Discovery of novel pyrimidine-based benzothiazole derivatives as potent cyclin-dependent kinase 2 inhibitors with anticancer activity;European Journal of Medicinal Chemistry;2019-10

Prolonged low-dose infusion for gemcitabine: a systematic review

;OncoTargets and Therapy;2019-06

5. Phomaketide A Inhibits Lymphangiogenesis in Human Lymphatic Endothelial Cells;Marine Drugs;2019-04-06